sirolimus
Commercial- Indications
- Castleman disease
Company intelligence / Profile preview
Every Cure
La Jolla, California, United Stateseverycure.org ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Every Cure has directly advanced at least two confirmed new uses for existing drugs through its AI-driven approach—including adalimumab for Castleman disease—and has supported or enabled the advancement of at least twenty-eight repurposed therapies overall. Their pilot identified over one hundred high-potential opportunities in an initial set of diseases.
- Therapeutic areas
- OncologyRare DiseasesImmunologyHematologyInfectious Diseases
- Modalities
- Small moleculeBiologicOther modalities as found in existing approved drugs (broad platform)
- Industry
- Academic Hospital/University/Research
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
BioPhy – partnership for advanced predictive analytics using BioLogicAI technology to optimize trial design and asset selection.Collaborations with academic institutions such as University of Pennsylvania/Penn Medicine,patient advocacy groups,philanthropic organizations,medical informatics firms,tech companies,biopharmaceutical companies,government agencies.
Beyond the preview
Go deeper on Every Cure.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Every Cure.